解郁复胃散联合穴位埋线治疗肝胃不和型功能性消化不良的临床疗效及对脑肠肽的影响

Clinical Efficacy of Jieyu Fuwei Powder Combined with Acupoint Catgut Embedding in the Treatment of Syndrome Functional Dyspepsia with Liver and Stomach Disharmony and Its Impact on Brain-Gut Peptides

    摘要
  • 摘要:
      目的  研究解郁复胃散联合穴位埋线治疗肝胃不和型功能性消化不良(Functional dyspepsia, FD)的临床疗效及对脑肠肽的影响。
      方法  纳入海安市中医院消化科及针灸科门诊62例肝胃不和型FD患者, 随机分为对照组和治疗组各31例(对照组脱落1例)。对照组予枸橼酸莫沙必利口服治疗, 治疗组予解郁复胃散口服联合穴位埋线治疗。治疗前后观察2组患者中医证候积分、改良消化不良严重程度评估量表(mSODA)评分, 比较2组临床有效率, 检测血清相关脑肠肽降钙素基因相关肽(Calcitonin-gene-related peptide, CGRP)、P物质(Substance P, SP)、胃动素(Motilin, MTL)及胃泌素(Gastrin, GAS)水平, 治疗期间观察2组患者不良反应发生情况。
      结果  治疗后, 2组患者两胁胀满、胃脘胀满、疼痛、嗳气等中医证候积分及mSODA评分明显改善(P < 0.05, P < 0.01), 治疗组优于对照组(P < 0.05, P < 0.01)。治疗组总有效率显著优于对照组(P < 0.05)。2组患者血清CGRP、SP水平明显下降(P < 0.01), MTL、GAS水平显著升高(P < 0.01), 治疗组优于对照组(P < 0.05, P < 0.01)。治疗组不良反应发生率低于对照组(P < 0.05)。
      结论  解郁复胃散联合穴位埋线治疗肝胃不和型FD疗效优于枸橼酸莫沙必利对照组, 其机制可能与调控脑肠肽水平有关。

     

    Abstract:
      OBJECTIVE  To study the clinical efficacy of Jieyu Fuwei Powder combined with acupoint catgut embedding in the treatment of functional dyspepsia (FD) with liver and stomach disharmony and its impact on brain gut peptides.
      METHODS  62 cases of FD patients with chronic liver and stomach disharmony were enrolled in the digestive department and acupuncture and moxibustion department of Hai'an Hospital of Chinese Medicine, and were randomly divided into a control group and a treatment group, with 31 cases in each group (1 case dropped out of the control group). The control group was orally treated with mosapride citrate, and the treatment group was treated with Jieyu Fuwei Powder combined with acupoint catgut embedding. The clinical efficiency of the two groups was compared. Before and after treatment, the TCM syndrome score, modified severity of dyspepsia assessment (mSODA) score of the two groups of patients were observed, and serum levels of brain-gut peptides Calcitonin gene related peptide (CGRP), Substance P (SP), Motilin (MTL), and Gastrin (GAS) were detected. During the treatment, the adverse reactions of the two groups of patients were observed.
      RESULTS  After treatment, the total effective rate of the treatment group was significantly higher than that of the control group (P < 0.05). The TCM syndrome scores of bilateral fullness, epigastric fullness, pain, and belching, as well as mSODA scores of the two groups of patients were improved compared to those before treatment (P < 0.05, P < 0.01), and the treatment group showed better efficacy than the control group (P < 0.05, P < 0.01). The levels of serum CGRP and SP in the two groups of patients were significantly decreased (P < 0.01), with average significant increases in MTL and GAS(P < 0.01), and the treatment group displayed better improvement than the control group (P < 0.05, P < 0.01). The incidence of adverse reactions in the treatment group was lower than that in the control group (P < 0.05).
      CONCLUSION  Jieyu Fuwei Powder combined with acupoint catgut embedding is more effective than mosapride citrate group in the treatment of FD with liver and stomach disharmony, and its mechanism may be related to the regulation of brain-gut peptides.

     

    • HTML全文
    • 参考文献(18)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回